Repligen to Report Fourth Quarter and Full Year 2024 Financial Results

Core Points - Repligen Corporation will report its fourth quarter 2024 financial results on February 20, 2025, with a press release issued before market opening [1] - A conference call will be held at 8:30 a.m. ET on the same day to discuss business updates and financial results for the three- and twelve-month periods ending December 31, 2024 [1] Company Overview - Repligen Corporation is a global life sciences company focused on developing and commercializing innovative bioprocessing technologies and systems for manufacturing biological drugs [3] - The company serves biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide, with a focus on areas such as Filtration and Fluid Management, Chromatography, Process Analytics, and Proteins [3] - The corporate headquarters is located in Waltham, Massachusetts, with manufacturing sites primarily in the U.S. and additional key locations in Estonia, France, Germany, Ireland, the Netherlands, and Sweden [3]